Citation Impact
Citing Papers
Cohort Study of the Impact of High-Dose Opioid Analgesics on Overdose Mortality
2015
The medical use of cannabis for reducing morbidity and mortality in patients with HIV/AIDS
2013
Sex differences in endogenous pain modulation by distracting and painful conditioning stimulation
2007
Efficacy of the NMDA-receptor antagonist memantine in patients with chronic phantom limb pain – results of a randomized double-blinded, placebo-controlled trial
2003
Glutamate receptor ion channels
2005 Standout
Constitutive activity of the δ‐opioid receptor expressed in C6 glioma cells: identification of non‐peptide δ‐inverse agonists
1999
International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors
2002 Standout
Glutamate Receptor Ion Channels: Structure, Regulation, and Function
2010 Standout
Functionally Different Agonists Induce Distinct Conformations in the G Protein Coupling Domain of the β2Adrenergic Receptor
2001 StandoutNobel
What we know, and don’t know, about the impact of state policy and systems-level interventions on prescription drug overdose
2014
Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications
2011 Standout
The Placebo Effect: Dissolving the Expectancy Versus Conditioning Debate.
2004 Standout
An Evidence-Based Review of Acute and Long-Term Effects of Cannabis Use on Executive Cognitive Functions
2011
Functional Gastroduodenal Disorders
2006 Standout
Buprenorphine versus methadone for opioid dependence: predictor variables for treatment outcome
2004
Adverse Health Effects of Marijuana Use
2014 Standout
Drug addiction: the neurobiology of disrupted self-control
2006
DeepLabCut: markerless pose estimation of user-defined body parts with deep learning
2018 Standout
Low-Dose Vaporized Cannabis Significantly Improves Neuropathic Pain
2012
Inhibition of kappa opioid receptors attenuated increased cocaine intake in rats with extended access to cocaine
2009
Pharmacological Treatment of the Overweight Patient
2007
Medicaid Coverage of Medications to Treat Alcohol and Opioid Dependence
2015
Drug addiction as a physical disease: The role of physical dependence and other chronic drug-induced neurophysiological changes in compulsive drug self-administration.
1998
Pain sensations to the cold pressor test in normally menstruating women: comparison with men and relation to menstrual phase and serum sex steroid levels
2007
Updating P300: An integrative theory of P3a and P3b
2007 Standout
Neural systems of reinforcement for drug addiction: from actions to habits to compulsion
2005 Standout
Abnormal brain activity in prefrontal brain regions in abstinent marijuana users
2004
Neurobiology of Relapse to Heroin and Cocaine Seeking: A Review
2002
Stress-evoked sterile inflammation, danger associated molecular patterns (DAMPs), microbial associated molecular patterns (MAMPs) and the inflammasome
2012
Cannabinoid hyperemesis: cyclical hyperemesis in association with chronic cannabis abuse
2004
Altered affective response in marijuana smokers: An FMRI study
2009
The Neural Basis of Addiction: A Pathology of Motivation and Choice
2005 Standout
Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers
2011
Stress-induced relapse to heroin and cocaine seeking in rats: a review
2000
Addiction Motivation Reformulated: An Affective Processing Model of Negative Reinforcement.
2004 Standout
Validity of four pain intensity rating scales
2011 Standout
The Effect of Intrinsic Efficacy on Opioid Tolerance
1995
Oral naltrexone maintenance treatment for opioid dependence
2011
Buprenorphine vs Methadone Maintenance Treatment for Concurrent Opioid Dependence and Cocaine Abuse
1997
Pleasures of the brain
2003
Sex, Gender, and Pain: A Review of Recent Clinical and Experimental Findings
2009 Standout
A survey on deep learning in medical image analysis
2017 Standout
The Third Intracellular Loop and the Carboxyl Terminus of β2-Adrenergic Receptor Confer Spontaneous Activity of the Receptor
2003 StandoutNobel
Clinicians' Attitudes and Beliefs About Opioids Survey (CAOS): Instrument Development and Results of a National Physician Survey
2013
Autoradiographic localization of dopamine D1 and D2 receptors in rat nucleus accumbens: Resistance to differential rearing conditions
1991 Standout
The Economic Burden of Opioid-Related Poisoning in the United States
2013
Menstrual cycle phase does not influence gender differences in experimental pain sensitivity
2009
A review of the published literature into cannabis withdrawal symptoms in human users
2002
Reinstatement and spontaneous recovery of nicotine seeking in rats
1997
Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial
2011
Using deep belief network modelling to characterize differences in brain morphometry in schizophrenia
2016
The rewards of music listening: Response and physiological connectivity of the mesolimbic system
2005 Standout
G‐protein receptor kinase 3 (GRK3) influences opioid analgesic tolerance but not opioid withdrawal
2004 StandoutNobel
Maintenance treatment with buprenorphine and naltrexone for heroin dependence in Malaysia: a randomised, double-blind, placebo-controlled trial
2008
Major Depressive Disorder
2008 Standout
Blockade of Effects of Smoked Marijuana by the CB1-Selective Cannabinoid Receptor Antagonist SR141716
2001
A Markerless 3D Computerized Motion Capture System Incorporating a Skeleton Model for Monkeys
2016
The molecular logic of endocannabinoid signalling
2003 Standout
Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review
2007 Standout
Imaginary Relish and Exquisite Torture: The Elaborated Intrusion Theory of Desire.
2005 Standout
Structure of the δ-opioid receptor bound to naltrindole
2012 StandoutNatureNobel
Measuring hedonic impact in animals and infants: microstructure of affective taste reactivity patterns
2000
Spontaneous Activation of β2- but Not β1-Adrenoceptors Expressed in Cardiac Myocytes from β1β2Double Knockout Mice
2000 StandoutNobel
Development of pharmacotherapies for drug addiction: a Rosetta Stone approach
2009
Why sex matters for neuroscience
2006 Standout
Recent advances in selective opioid receptor agonists and antagonists
2003
μ-Opioid Receptor-Stimulated Guanosine-5′-O-(γ-thio)-triphosphate Binding in Rat Thalamus and Cultured Cell Lines: Signal Transduction Mechanisms Underlying Agonist Efficacy
1997
A cannabinoid mechanism in relapse to cocaine seeking
2001
Applying extinction research and theory to cue‐exposure addiction treatments
2002
The reinstatement model of drug relapse: history, methodology and major findings
2002
Unlimited Access to Heroin Self-Administration: Independent Motivational Markers of Opiate Dependence
2006
Neurocircuitry of Addiction
2009 Standout
Chiral Brønsted acid catalyzed Friedel–Crafts alkylation reactions
2009 Standout
Methadone Versus Buprenorphine With Contingency Management or Performance Feedback for Cocaine and Opioid Dependence
2005
Emergency Department Visits and Overdose Deaths From Combined Use of Opioids and Benzodiazepines
2015
Biological basis of sex differences in drug abuse: preclinical and clinical studies
2002
Dopamine, learning and motivation
2004 Standout
The role of inflammation in depression: from evolutionary imperative to modern treatment target
2015 Standout
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
The Role and Regulation of Adenosine in the Central Nervous System
2001 Standout
Enhanced Morphine Analgesia in Mice Lacking β-Arrestin 2
1999 StandoutScienceNobel
Guidelines for the psychosocially assisted pharmacological treatment of opioid dependence
2009
High-Risk Use by Patients Prescribed Opioids for Pain and Its Role in Overdose Deaths
2014
Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design
2018 Standout
Peptidic delta opioid receptor agonists produce antidepressant-like effects in the forced swim test and regulate BDNF mRNA expression in rats
2005
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence
2014 Standout
β-Phenylethylamines and the isoquinoline alkaloids
2004
Opioid maintenance: a comparative review of pharmacological strategies
2006
Glutamate Transmission in the Nucleus Accumbens Mediates Relapse in Cocaine Addiction
2000
Synthesis of Gly-ψ[(Z)CF═CH]-Phe, a Fluoroalkene Dipeptide Isostere, and Its Incorporation into a Leu-enkephalin Peptidomimetic
2016
The Prescription Opioid and Heroin Crisis: A Public Health Approach to an Epidemic of Addiction
2015 Standout
CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016
2016 Standout
Executive Functions
2012 Standout
Opioids in the Management of ChronicNon-Cancer Pain: An Update of AmericanSociety of the Interventional Pain Physicians’(ASIPP) Guidelines
2008
Actions of Caffeine in the Brain with Special Reference to Factors That Contribute to Its Widespread Use
1999 Standout
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
Buprenorphine Treatment for Hospitalized, Opioid-Dependent Patients
2014
Opioid Prescriptions for Chronic Pain and Overdose
2010 Standout
Vital signs: variation among States in prescribing of opioid pain relievers and benzodiazepines - United States, 2012.
2014
Office-Based Treatment of Opiate Addiction with a Sublingual-Tablet Formulation of Buprenorphine and Naloxone
2003
The Medicinal Use of Cannabis and Cannabinoids—An International Cross-Sectional Survey on Administration Forms
2013
The Metabolic Syndrome
2008 Standout
Cannabinoids for Medical Use
2015 Standout
Psychosocial and pharmacological treatments versus pharmacological treatments for opioid detoxification
2011
Opioids, Reward and Addiction: An Encounter of Biology, Psychology, and Medicine
1999
International Union of Pharmacology. XXV. Nomenclature and Classification of Adenosine Receptors
2001 Standout
Cross-Dehydrogenative Coupling (CDC): Exploring C−C Bond Formations beyond Functional Group Transformations
2008 Standout
Spontaneous Activation of β2- but Not β1-Adrenoceptors Expressed in Cardiac Myocytes from β1β2 Double Knockout Mice
2000 StandoutNobel
Medicinal and Recreational Marijuana Use Among HIV-Infected Women in the Women's Interagency HIV Study (WIHS) Cohort, 1994–2010
2012
Nitrated Confined Imidodiphosphates Enable a Catalytic Asymmetric Oxa-Pictet–Spengler Reaction
2016 StandoutNobel
NEURAL MECHANISMS OF ADDICTION: The Role of Reward-Related Learning and Memory
2006 Standout
Cocaine Administered into the Medial Prefrontal Cortex Reinstates Cocaine-Seeking Behavior by Increasing AMPA Receptor-Mediated Glutamate Transmission in the Nucleus Accumbens
2002
Neuropsychology and neuropharmacology of P3a and P3b
2006
Works of Sandra D. Comer being referenced
Convulsive effects of systemic administration of the delta opioid agonist BW373U86 in mice.
1993
Clocinnamox: a novel, systemically-active, irreversible opioid antagonist.
1992
Effects of buprenorphine and naltrexone on reinstatement of cocaine-reinforced responding in rats.
1993
Predictors of Marijuana Relapse in the Human Laboratory: Robust Impact of Tobacco Cigarette Smoking Status
2012
Dronabinol and Marijuana in HIV-Positive Marijuana Smokers
2007
Opioid Maintenance Treatment as a Harm Reduction Tool for Opioid-Dependent Individuals in New York City: The Need to Expand Access to Buprenorphine/Naloxone in Marginalized Populations
2012
The NMDA antagonist memantine attenuates the expression of opioid physical dependence in humans
2001
Alprazolam increases food intake in humans
1997
Challenges in the Development of Prescription Opioid Abuse-deterrent Formulations
2007
Depot naltrexone: long-lasting antagonism of the effects of heroin in humans
2002
Acute Physiological and Behavioral Effects of Intranasal Methamphetamine in Humans
2007
Buprenorphine sublingual tablets: effects on IV heroin self-administration by humans
2001
Management of relapse in naltrexone maintenance for heroin dependence
2007
Comparison of the Analgesic Effects of Dronabinol and Smoked Marijuana in Daily Marijuana Smokers
2013
Combined effects of buprenorphine and a nondrug alternative reinforcer on IV cocaine self-administration in rats maintained under FR schedules
1996
Intravenous Buprenorphine Self-Administration by Detoxified Heroin Abusers
2002
Brief overdose education can significantly increase accurate recognition of opioid overdose among heroin users
2013
Sex Differences and Hormonal Influences on Response to Cold Pressor Pain in Humans
2006
Abuse Liability of Prescription Opioids Compared to Heroin in Morphine-Maintained Heroin Abusers
2007
Intermittent Marijuana Use Is Associated with Improved Retention in Naltrexone Treatment for Opiate‐Dependence
2009
Comparison of smoked marijuana and oral Δ 9 -tetrahydrocannabinol in humans
2002
Glial modulators: a novel pharmacological approach to altering the behavioral effects of abused substances
2012
Abstinence symptoms following oral THC administration to humans
1999
Polydrug abuse: A review of opioid and benzodiazepine combination use
2012
Betting on change: Modeling transitional probabilities to guide therapy development for opioid dependence.
2009
Depot naltrexone: antagonism of the reinforcing, subjective, and physiological effects of heroin
2006
Buprenorphine maintenance and mu-opioid receptor availability in the treatment of opioid use disorder: Implications for clinical use and policy
2014
Self-Administration of Intravenous Buprenorphine and the Buprenorphine/Naloxone Combination by Recently Detoxified Heroin Abusers
2002
Reducing hospital presentations for opioid overdose in patients treated with sustained release naltrexone implants
2005
Abstinence symptoms following smoked marijuana in humans
1999
Effect of fenfluramine on food intake, mood, and performance of humans living in a residential laboratory
1996
Food deprivation affects extinction and reinstatement of responding in rats
1995
The effects of a monetary alternative on marijuana self-administration
1997
Buprenorphine/naloxone reduces the reinforcing and subjective effects of heroin in heroin-dependent volunteers
2005
Sustained-release naltrexone: novel treatment for opioid dependence
2007
Choice between money and intranasal heroin in morphine-maintained humans
1997
Injectable, Sustained-Release Naltrexone for the Treatment of Opioid Dependence
2006
Effects of caffeine withdrawal on humans living in a residential laboratory.
1997
Effects of buprenorphine on candy and sweetened fluid self-administration by rhesus monkeys
2002
Animal models of relapse.
1996
Effects of caffeine withdrawal on humans living in a residential laboratory.
1997